Author: Alan Condon

Three spine surgeons discuss how a single-payer healthcare system would impact spine practice in the U.S.

Richard Menger, MD, is chief of complex spine surgery and assistant professor of neurosurgery at University of South Alabama Health in Mobile.

In a recent study, orthopedic surgeon Kenneth Pettine, DO, tested his mesenchymal stem cell treatment for osteoarthritis on 33 former Navy SEALs.

Osseus Fusion Systems on Feb. 4 launched Aries-TS, its 3D-printed transforaminal lumbar interbody fusion device.

Safe Orthopaedics recently appointed Nikolaus Beyer as chief commercial officer.

Medicrea's UNiD Adaptive Spine Intelligence software for spine surgery recently exceeded 5,000 cases.

Orthofix signed an asset purchase agreement with German company Wittenstein SE Feb. 4 to acquire its Fitbone platform.

Here are the 10 most-read articles featured on Becker's Spine Review in January:

Keith Norvill, DO, recently joined CHI St. Vincent Neurosurgery Clinic in Hot Springs, Ark.

Zolgensma, a gene therapy drug for spinal muscular atrophy, has been on the market since June 2019 and is widely reported to be the most expensive drug in the world.